NeuroBo Pharmaceuticals
Presence
NeuroBo Pharmaceuticals is a company listed under the stock ticker NRBO (US).
Executives
View the org chart displaying its 13 main executives
Most searched biographies at NeuroBo Pharmaceuticals
Popular executive movements at NeuroBo Pharmaceuticals
- Marshall Woodworth, who was Acting Chief Financial Officer, is promoted to Chief Financial Officer (posted on March 5 2024).
- James Tursi has joined the company as Director (posted on November 7 2023).
Create your alert
to follow the executive moves at NeuroBo Pharmaceuticals.
Biotechnology
NeuroBo Pharmaceuticals has 2,292 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Lycia Therapeutics has just announced a $107 Million fundraising (posted on May 15 2024).
- Attovia Therapeutics has just announced a $150 Million fundraising (posted on May 14 2024).
- Bruker has announced the acquisition of NanoString Technologies (posted on May 13 2024).
Popular contacts in Biotechnology
News
Press releases by NeuroBo Pharmaceuticals
- NeuroBo Pharmaceuticals, Inc. Expands Management Team with the Appointment of Matthew Bardin, PharmD, BCPS as Senior Vice President Operations | NeuroBo Pharmaceuticals, Inc.
- NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results | NeuroBo Pharmaceuticals, Inc.
- NeuroBo Pharmaceuticals, Inc. Expands Scientific Advisory Board with Appointment of Danamarie Belpulsi, M.D. | NeuroBo Pharmaceuticals, Inc.
- NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors | NeuroBo Pharmaceuticals, Inc.
Social media about NeuroBo Pharmaceuticals
- NeuroBo Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
- NeuroBo Pharmaceuticals on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Mark Glickman 
Call NeuroBo Pharmaceuticals at +1 248...
